iifl-logo-icon 1

Torrent Pharmaceuticals Ltd Balance Sheet

3,421.35
(0.64%)
Dec 26, 2024|03:40:34 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

169.23

169.23

84.62

84.62

Preference Capital

0

0

0

0

Reserves

6,659.53

6,286.73

6,260.8

5,945.48

Net Worth

6,828.76

6,455.96

6,345.42

6,030.1

Minority Interest

Debt

3,344.2

4,575.47

3,347.51

4,404.14

Deferred Tax Liability Net

1,061.19

1,014.15

990.42

998.58

Total Liabilities

11,234.15

12,045.58

10,683.35

11,432.82

Fixed Assets

8,212.15

8,669.78

6,818.75

7,329.35

Intangible Assets

Investments

463.31

361.21

367.64

313.92

Deferred Tax Asset Net

405.38

612.85

796.86

1,026.91

Networking Capital

2,044.55

2,254.13

2,630.64

2,696.22

Inventories

1,565.59

1,602.23

1,797.11

1,911.74

Inventory Days

97.28

108.17

Sundry Debtors

1,571.94

1,729.44

1,541.35

1,544.26

Debtor Days

83.44

87.38

Other Current Assets

454.84

361.66

558.25

567.02

Sundry Creditors

-779.3

-654.8

-639.56

-670.61

Creditor Days

34.62

37.94

Other Current Liabilities

-768.52

-784.4

-626.51

-656.19

Cash

108.76

147.61

69.46

66.42

Total Assets

11,234.15

12,045.58

10,683.35

11,432.82

Torrent Pharma. : related Articles

Torrent Pharma announces acquisition of 3 anti-diabetes brands
5 Dec 2024|09:04 AM

Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.

Read More
USFDA concludes Torrent Pharma’s inspection with VAI
22 Nov 2024|02:58 PM

The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.

Read More
Torrent Pharma promoter to pare 2.9% stake via block deal
30 Oct 2024|11:48 AM

The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.

Read More
Torrent Pharma Q2 Profit Soars 17.3%, Revenue Grows 8.6%
28 Oct 2024|12:16 PM

When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.

Read More
Torrent Pharma’s Shelcal 500 fails CDSCO quality test
27 Sep 2024|02:40 PM

In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.

Read More
Top 10 Stocks for today - 27th September, 2024
27 Sep 2024|09:35 AM

Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.

Read More
Torrent Pharma logs 20% y-o-y growth in Q1 net profit
24 Jul 2024|12:36 PM

The company announced that its India business grew by 10% year on year in the June quarter, with sales rising to ₹1,635 Crore from ₹1,426 Crore in Q1 FY24.

Read More
Top 10 stocks for today – 24th July 2024
24 Jul 2024|08:58 AM

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Bajaj Finance, Vedanta, etc.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp